Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

396.62
-4.3800-1.09%
Volume:1.25M
Turnover:496.12M
Market Cap:101.69B
PE:28.19
High:402.39
Open:400.09
Low:393.05
Close:401.00
52wk High:519.88
52wk Low:362.50
Shares:256.39M
Float Shares:255.58M
Volume Ratio:0.73
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.07
EPS(LYR):-2.0768
ROE:22.77%
ROA:13.09%
PB:5.92
PE(LYR):-190.98

Loading ...

Vertex Pharmaceuticals: Buy Rating Upgraded to Overweight Amid Promising Pipeline and Strong Financial Position

TIPRANKS
·
Aug 07

Vertex's (NASDAQ:VERX) Returns On Capital Are Heading Higher

Simply Wall St.
·
Aug 06

Vertex Q2 Adj. EPS $0.15 Beats $0.14 Estimate, Sales $184.559M Miss $184.595M Estimate

Benzinga
·
Aug 06

Vertex Pharmaceuticals Incorporated : Wells Fargo Raises to Overweight From Equal Weight

THOMSON REUTERS
·
Aug 06

Vertex Pharmaceuticals: Strong Growth and Strategic Advances

TIPRANKS
·
Aug 06

Nasdaq Net Change Percentage Gainers & Losers

Dow Jones
·
Aug 06

These Analysts Cut Their Forecasts On Vertex Pharmaceuticals After Q2 Results

Benzinga
·
Aug 06

BUZZ-U.S. STOCKS ON THE MOVE-Axon, Cummins, Pfizer

Reuters
·
Aug 06

Vortex Energy Commences ANT Survey at Robinsons River Salt Project

TIPRANKS
·
Aug 06

Bernstein Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 06

Cantor Fitzgerald Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 06

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-08-05

Reuters
·
Aug 05

Stock Track | Vertex Pharmaceuticals Plummets 15.32% as Pain Drug VX-993 Fails Mid-Stage Trial

Stock Track
·
Aug 05

Scotiabank Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 05

BUZZ-U.S. STOCKS ON THE MOVE-Caterpillar, Pfizer, Zebra Technologies

Reuters
·
Aug 05

Vertex price target lowered to $478 from $550 at H.C. Wainwright

TIPRANKS
·
Aug 05

Vertex Pharmaceuticals Inc : Scotiabank Cuts Target Price to $438 From $442

THOMSON REUTERS
·
Aug 05

Vertex Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $458.00 From $503.00

THOMSON REUTERS
·
Aug 05

Stock Track | Vertex Pharmaceuticals Plunges 14.64% Pre-market on Pain Drug Failure, Pipeline Concerns

Stock Track
·
Aug 05

Vertex Pharmaceuticals Inc : Bernstein Raises Target Price to $471 From $462

THOMSON REUTERS
·
Aug 05